IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/14/2018 |
| Start Date: | November 2015 |
| End Date: | April 2019 |
Does Contrast-Enhanced Ultrasound Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?
This is a pilot study to investigate whether contrast-enhanced ultrasound (CEUS) may help
evaluate segmental differences in renal perfusion better than Doppler Ultrasound and thus
help direct the biopsy to the most abnormal part of the renal cortex. This should maximize
detection and increase the odds of demonstrating the true grade/severity of the
histopathological abnormality.
evaluate segmental differences in renal perfusion better than Doppler Ultrasound and thus
help direct the biopsy to the most abnormal part of the renal cortex. This should maximize
detection and increase the odds of demonstrating the true grade/severity of the
histopathological abnormality.
Inclusion
- Ability to provide informed consent
- Male and female >18 years
- Patients undergoing renal transplant ultrasound-guided percutaneous biopsy within 24
months post transplant including patients undergoing biopsy to evaluate a recent rise
in serum creatinine so called for cause biopsies and patients undergoing routine
protocol (surveillance) biopsies without other evident of renal dysfunction
Exclusion:
- Pregnant women or women who are nursing an infant are not able to participate in this
study
- Known patent forearm ovale (PFO)
- Significant heart disease
We found this trial at
1
site
13400 E. Shea Blvd.
Scottsdale, Arizona 85259
Scottsdale, Arizona 85259
480-301-8000
Principal Investigator: J. Scott Kriegshauser, M.D.
Phone: 480-342-0349
Mayo Clinic Arizona Mayo Clinic in Arizona provides medical care for thousands of people from...
Click here to add this to my saved trials
